(1S,3aS,3bS,9aR,9bS,11aS)-N,N-diethyl-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[i]phenanthridine-1-carboxamide

ID: ALA1762031

Chembl Id: CHEMBL1762031

Max Phase: Preclinical

Molecular Formula: C24H38N2O2

Molecular Weight: 386.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CC)C(=O)[C@H]1CC[C@H]2[C@@H]3CNC4=C(C)C(=O)CC[C@]4(C)[C@H]3CC[C@]12C

Standard InChI:  InChI=1S/C24H38N2O2/c1-6-26(7-2)22(28)19-9-8-17-16-14-25-21-15(3)20(27)11-13-24(21,5)18(16)10-12-23(17,19)4/h16-19,25H,6-14H2,1-5H3/t16-,17-,18-,19+,23-,24+/m0/s1

Standard InChI Key:  OJXBUKBKWQOFGZ-KCQAWASRSA-N

Alternative Forms

  1. Parent:

    ALA1762031

    ---

Associated Targets(Human)

SRD5A2 Tclin Steroid 5-alpha-reductase 2 (937 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.58Molecular Weight (Monoisotopic): 386.2933AlogP: 4.16#Rotatable Bonds: 3
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.49CX LogP: 3.07CX LogD: 3.07
Aromatic Rings: Heavy Atoms: 28QED Weighted: 0.79Np Likeness Score: 1.13

References

1. Thomas ST, Yang X, Sampson NS..  (2011)  Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.,  21  (8): [PMID:21439822] [10.1016/j.bmcl.2011.03.004]
2. Kumar R, Kumar M.  (2013)  3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5-reductase inhibitors,  22  (1): [10.1007/s00044-012-0006-1]

Source